{"id":537056,"date":"2021-09-10T16:20:05","date_gmt":"2021-09-10T20:20:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/"},"modified":"2021-09-10T16:20:05","modified_gmt":"2021-09-10T20:20:05","slug":"abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/","title":{"rendered":"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference"},"content":{"rendered":"

<\/p>\n

AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference<\/b><\/p>\n

VANCOUVER–(BUSINESS WIRE<\/a>)–
\nAbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the BofA Securities\u00a0 \u2013 Tech Solutions for Drug Discovery Conference on Monday, September 20, 2021, at 9:00 a.m. Pacific Time.\n<\/p>\n

\nA live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera\u2019s Investor Relations website<\/a>. A replay will be available through the same link following the presentation.\n<\/p>\n

About AbCellera Biologics Inc<\/b>.\n<\/p>\n

\nAbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com<\/a>.\n<\/p>\n

\nSource: AbCellera Biologics Inc.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210910005540\/en\/<\/a><\/span><\/p>\n

Inquiries
\n<\/b>
Media: Jessica Yingling, Ph.D.; media@abcellera.com<\/a>, +1(236)521-6774
\n
Business Development: Neil Berkley, Ph.D.; bd@abcellera.com<\/a>, +1(604)559-9005
\n
Investor Relations: Melanie Solomon; ir@abcellera.com<\/a>, +1(778)729-9116\n<\/p>\n

KEYWORDS:<\/b> New York United States North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference VANCOUVER–(BUSINESS WIRE)– AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the BofA Securities\u00a0 \u2013 Tech Solutions for Drug Discovery Conference on Monday, September 20, 2021, at 9:00 a.m. Pacific Time. A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera\u2019s Investor Relations website. A replay will be available through the same link following the presentation. About AbCellera Biologics Inc. AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with … <\/p>\n

Continue reading “AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-537056","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference VANCOUVER–(BUSINESS WIRE)– AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the BofA Securities\u00a0 \u2013 Tech Solutions for Drug Discovery Conference on Monday, September 20, 2021, at 9:00 a.m. Pacific Time. A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera\u2019s Investor Relations website. A replay will be available through the same link following the presentation. About AbCellera Biologics Inc. AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with … Continue reading "AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-10T20:20:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference\",\"datePublished\":\"2021-09-10T20:20:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/\"},\"wordCount\":228,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/\",\"name\":\"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-09-10T20:20:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/","og_locale":"en_US","og_type":"article","og_title":"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference - Market Newsdesk","og_description":"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference VANCOUVER–(BUSINESS WIRE)– AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the BofA Securities\u00a0 \u2013 Tech Solutions for Drug Discovery Conference on Monday, September 20, 2021, at 9:00 a.m. Pacific Time. A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera\u2019s Investor Relations website. A replay will be available through the same link following the presentation. About AbCellera Biologics Inc. AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with … Continue reading \"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-10T20:20:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference","datePublished":"2021-09-10T20:20:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/"},"wordCount":228,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/","name":"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-09-10T20:20:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210910005540r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abcellera-to-present-virtually-at-the-bofa-securities-tech-solutions-for-drug-discovery-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AbCellera to Present Virtually at the BofA Securities \u2013 Tech Solutions for Drug Discovery Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/537056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=537056"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/537056\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=537056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=537056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=537056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}